| Neglia, Joseph P |
NCT00082745: Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors |
|
|
| Recruiting | N/A | 3885 | Europe, Canada, US, RoW | Laboratory Biomarker Analysis, Questionnaire Administration | Children's Oncology Group, National Cancer Institute (NCI) | Childhood Malignant Neoplasm | 12/04 | | | |
| Recruiting | N/A | 900 | Canada, US | Biospecimen collection, Vision assessment, Questionnaire administration, Quality of life assessment, Laboratory Biomarker Analysis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Retinoblastoma, Cancer Survivor, Biological Sibling, Intraocular Retinoblastoma, Unilateral Retinoblastoma | 01/30 | 01/31 | | |
NCT00736749: Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies |
|
|
| Recruiting | N/A | 5000 | US | Assessment of Therapy Complications, Questionnaire Administration | Children's Oncology Group, National Cancer Institute (NCI) | Hematopoietic Cell Transplantation Recipient, Leukemia, Solid Tumor | 01/00 | | | |
| kitsch, Kristen |
| Recruiting | 1/2 | 144 | US | AVM0703, Supra-Pharmacologic Dexamethasone Phosphate | AVM Biotechnology Inc, Medpace, Inc. | Lymphoid Malignancies | 04/25 | 06/25 | | |
NCT06182579: Phase I Study of RiMO-401 With Radiation in Advanced Tumors |
|
|
| Recruiting | 1 | 24 | US | RiMO-401, Radiation | Coordination Pharmaceuticals, Inc. | Advanced Solid Tumor, Intratumoral Injection | 01/26 | 07/26 | | |
NCT03444714: Phase I Study of RiMO-301 With Radiation in Advanced Tumors |
|
|
| Recruiting | 1 | 18 | US | RiMO-301, Radiotherapy | Coordination Pharmaceuticals, Inc., University of Chicago | Advanced Tumors | 09/24 | 12/24 | | |
VEN-OM, NCT04926285: Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) |
|
|
| Recruiting | 1 | 30 | US | Omacetaxine, Venetoclax | University of Illinois at Chicago | Relapsed or Refractory Hematologic Malignancies | 07/25 | 07/25 | | |
| Not yet recruiting | N/A | 225 | US | Pharmacist delivered symptom monitoring and management | Medical College of Wisconsin, National Cancer Institute (NCI) | Breast Cancer Early Stage Breast Cancer (Stage 1-3), Endocrine Therapy | 07/28 | 06/29 | | |
| Recruiting | N/A | 900 | Canada, US | Biospecimen collection, Vision assessment, Questionnaire administration, Quality of life assessment, Laboratory Biomarker Analysis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Retinoblastoma, Cancer Survivor, Biological Sibling, Intraocular Retinoblastoma, Unilateral Retinoblastoma | 01/30 | 01/31 | | |
| Pallin, Kendra |
| Recruiting | N/A | 900 | Canada, US | Biospecimen collection, Vision assessment, Questionnaire administration, Quality of life assessment, Laboratory Biomarker Analysis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Retinoblastoma, Cancer Survivor, Biological Sibling, Intraocular Retinoblastoma, Unilateral Retinoblastoma | 01/30 | 01/31 | | |
